ATAGI recommendations on the use of a third primary dose of COVID-19 vaccine in individuals who are severely immunocompromised
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of a third primary dose of COVID-19 vaccine in individuals who are severely immunocompromised.
Downloads
ATAGI recommendations on the use of a third primary dose of COVID-19 vaccine in individuals who are severely immunocompromised
This update contains no new information but is just editorial changes.
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Publication date:
25 March 2022
Last updated:
29 April 2022
Publication type:
Guideline
Intended audience:
General public
Part of a collection: